Stock Guru Profile
Demand for natural medicines seems insatiable: Americans now spend an estimated $20 billion annually on herbal remedies for weight loss or to treat back pain, dementia or cancer, studies have found. Because of growing demand, the number of products has skyrocketed. eFoodSafety.com, Inc. announced that it has purchased from NutraLab, Inc. all rights, title, and interest to Cinnergen™, a once-a-day formula made from 15 whole foods that contain no fats, carbohydrates, sugar, or calories that is designed to regulate blood sugar.
Diabetes is one of the most prevalent diseses in the United States.
Under 20 years of age: 176,500, or 0.22% of all people in this age group have diabetes. About one in every 400 to 600 children and adolescents has type 1 diabetes. Two (2) million adolescents (or 1 in 6 overweight adolescents) aged 12-19 have pre-diabetes.
Age 20 years or older: 20.6 million, or 9.6% of all people in this age group have diabetes.
Age 60 years or older: 10.3 million, or 20.9% of all people in this age group have diabetes.
Cinnergen™ is now well entrenched with several national retail chains, such as GNC, Vitamin Shoppe, and various other independent retailers. Indications are that other major national retailers may be featuring Cinnergen™ in the very near future.
Patricia Gruden, President and CEO of eFoodSafety.com, Inc. stated, “We purchased the product after quantifiable sales patterns were established and consistent and increasing sell-through of the product was demonstrated. It is our goal that through this purchase we will create reoccurring and increasing revenue. In addition, we intend to leverage and build on our existing retail pipeline as the Company has various products it intends to bring to market in the near future.”
Gruden further commented, “We remain focused on executing our business plan with the goal of enhancing shareholder value. That other pharmaceutical companies are devoting considerable resources to the diabetes market tells us that our purchasing a proven product with existing distribution channels in that market has potential exponential growth.”
Source: eFoodSafety.com Inc. Consumer Reports, Business Wire, and the American Diabetes Association
Redwood Consultants, LLOC
Jens Dalsgaard, Managing Director
250 Bel Marin Keys Blvd., #A-1
Novato, CA 94949
Telephone: 415.884.0348
Fax: 415.884.0361
eFoodSafety.com, Inc.
7702 East Doubletree Ranch Road
Suite 300
Scottsdale, AZ 85258
Telephone: 480.607.2606
Fax: 480.348.3999
President/CEO Patricia Ross-Gruden
About eFoodSafety.com, Inc.: eFoodSafety.com, Inc. is dedicated to improving health conditions around the world through its innovative technologies. The company’s Knock-Out Technologies, Ltd. subsidiary has developed an environmentally safe sporicidal product formulated entirely of food-grade components that eradicates anthrax and a germicidal product, Citroxin (formerly named Big Six Plus) – EPA Reg. No. 82723-1 that kills six major bacteria: E-coli, Listeria, Pseudomonas, Salmonella, Staphylococcus, and Streptococcus, Avian Influenza, and Black Mold. The sporicidal product has completed its final efficacy laboratory study requisite for EPA registration. In the study, it eradicated both Clostridium Sporogenes and Bacillus Subtilis with 100% efficacy on both hard and porous surfaces. The company’s MedElite, Inc. subsidiary distributes clinically proven products to physicians who then prescribe the products for their patients. It recently became the owner of the Talsyn(TM)-CI/bid Scar Cream, that has been clinically proven to facilitate and improve the appearance, redness and strength of scars (www.talsyn.com), as well as seven (7) other products in the Talsyn(TM) line. The company is also is a distributor for Cinnergen(TM), a non-prescription liquid whole food nutritional supplement that promotes healthy glucose metabolism (www.cinnergen.com), and Trimmendous(TM), a weight loss formula focusing on the body’s 24-hour metabolic processes. The company has entered into a joint venture agreement with CK41 Direct, Inc. to launch the PurEffect(TM) anti-acne skin care system.
Disclosure: Pentony Enterprises LLC was compensated 100,000 free trading shares from a non-controlling third party for profile coverage. Pentony Enterprises LLC is not a registered investment advisers or broker/dealers. Pentony Enterprises LLC makes no recommendation that the purchase of securities of companies profiled in this web site is suitable or advisable for any person or that an investment such securities will be profitable. In general, given the nature of the companies profiled and the lack of an active trading market for their securities, investing in such securities is highly speculative and carries a high degree of risk.It is the policy of Pentony Enterprises LLC to sell all shares of this and any company featured. Anyone considering any company we feature in consideration for free trading shares should consider this. Pentony Enterprises no longer holds shares.
Safe Harbor Statement: All statements contained herein, as well as oral statements that may be made by the Company or by officers, directors or employees of the Company acting on the Company’s behalf, that are not statements of historical fact, constitute “forward-looking statements” and are made pursuant to the Safe-Harbor provisions of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that could cause the actual results of the company to be materially different from the historical results or from any future results expressed or implied by such forward-looking statements. Such risks and uncertainties are outlined in the Company’s Annual Report on Form 10-K as filed with the Securities and Exchange Commission. The Company is not obligated to revise or update any forward-looking statements in order to reflect events or circumstances that may arise after the date of this release.
Disclosure: StockGuru.com is owned and operated by Pentony Enterprises LLC,9555 Lebanon Road, Suite 103, Frisco, Texas 75035. Telephone: (214) 458-4258. Web: StockGuru.com. Email: Publisher@stockguru.com.